Repros Therapeutics Incorporated - symbol RPRX - reported data from its recently completed ZA-204 study. The Oral Androxal Achieved Equivalent 24 Hour Average Testosterone Levels Compared to the leading FDA-approved topical gel used per manufacturer’s instructions
